Related Experiment Video
Updated: Oct 30, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
The Roles of DNA Demethylases in Triple-Negative Breast Cancer
Shoghag Panjarian1, Jean-Pierre J Issa1
1Coriell Institute Research Department, Coriell Institute for Medical Research, Camden, NJ 08103, USA.
Abstract:
Triple-negative breast cancers (TNBCs) are very heterogenous, molecularly diverse, and are characterized by a high propensity to relapse or metastasize. Clinically, TNBC remains a diagnosis of exclusion by the lack of hormone receptors (Estrogen Receptor (ER) and Progesterone Receptor (PR)) as well as the absence of overexpression and/or amplification of HER2. DNA methylation plays an important role in breast cancer carcinogenesis and TNBCs have a distinct DNA methylation profile characterized by marked hypomethylation and lower gains of methylations compared to all other subtypes. DNA methylation is regulated by the balance of DNA methylases (DNMTs) and DNA demethylases (TETs). Here, we review the roles of TETs as context-dependent tumor-suppressor genes and/or oncogenes in solid tumors, and we discuss the current understandings of the oncogenic role of TET1 and its therapeutic implications in TNBCs.
Insights
Triple-negative breast cancer (TNBC) is a diverse subtype with a high risk of metastasis. TET1 may play an oncogenic role in TNBC, offering potential new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Triple-negative breast cancer (TNBC) is molecularly diverse and prone to relapse and metastasis.
- TNBC is diagnosed by the absence of Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2.
- Distinct DNA methylation profiles, including hypomethylation, characterize TNBCs.
Purpose of the Study:
- To review the dual role of ten-eleven translocation (TET) enzymes as tumor suppressors or oncogenes in solid tumors.
- To discuss the oncogenic role of TET1 in TNBC.
- To explore the therapeutic implications of TET1 in TNBC.
Main Methods:
- Literature review of TET enzyme functions in solid tumors.
- Analysis of existing research on DNA methylation in TNBC.
- Discussion of TET1's specific role and therapeutic potential in TNBC.
Main Results:
- TET enzymes exhibit context-dependent roles as tumor suppressors or oncogenes.
- TET1 is implicated in the oncogenesis of TNBC.
- Understanding TET1's function provides insights into potential therapeutic strategies for TNBC.
Conclusions:
- TET enzymes are critical regulators of DNA methylation with diverse roles in cancer.
- TET1's oncogenic function in TNBC presents a promising avenue for targeted therapies.
- Further research into TET1 is crucial for developing novel treatments for triple-negative breast cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
MicroRNAs
MicroRNAs
Negative Regulator Molecules

